Identification of a Proinflammatory Biomarker Differentiating Meniere's disease and Vestibular Migraine

Date Added
April 7th, 2020
PRO Number
Pro00097605
Researcher
Habib Rizk

List of Studies

Keywords
Ears, Hearing, Inflammation
Summary

Meniere's disease is a common cause of vertigo that becomes more common with age. Unfortunately, Meniere's disease and vestibular migraine have significant overlap and are sometimes difficult to diagnose. This is due to a lack of understanding of the true cause of Meniere's disease. Due to the lack of a biomarker (an objective test), the diagnosis of Meniere's disease has been based on clinical history and hearing loss. We are exploring ways to differentiate Meniere's disease and vestibular migraine, potentially through a lab test. In addition, identifying biomarkers may help early diagnosis and direct more personalized treatment strategies, especially early on before hearing loss occurs.

Institution
MUSC
Recruitment Contact
Habib Rizk
843 876-0112
rizkh@musc.edu

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

Date Added
October 1st, 2019
PRO Number
Pro00091200
Researcher
Habib Rizk

List of Studies

Keywords
Drug Studies, Ears
Summary

As of yet, the cause of Meniere's disease is uncertain and there is no cure. Given the lack of high level evidence for treatments, we seek to perform a randomized, placebo-controlled, double-blind, crossover, pilot trial of venlafaxine for treating Meniere's disease. Venlafaxine is a safe and well-tolerated medication. It has never been trialed in Meniere's disease, but there is evidence that it could be effective in helping with vertigo attacks and other aspects of the disorder.

Institution
MUSC
Recruitment Contact
Habib Rizk
2154590435
rizkh@musc.edu



-- OR --